Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension
- 14 October 2003
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 481 (1) , 91-100
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With HypertensionHypertension, 2003
- Free Radicals and Lipid Signaling in Endothelial CellsAntioxidants & Redox Signaling, 2003
- Endothelin-1 Increases Vascular Superoxide via Endothelin A –NADPH Oxidase Pathway in Low-Renin HypertensionCirculation, 2003
- Plasma Hydrogen Peroxide Production in Human Essential HypertensionHypertension, 2000
- Endothelium-dependent Vasodilation in Hypertension: A ReviewBlood Pressure, 2000
- Superoxide Anion Production Is Increased in a Model of Genetic HypertensionHypertension, 1999
- Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F 2αHypertension, 1999
- Normalization of Blood Pressure and Renal Vascular Resistance in SHR With a Membrane-Permeable Superoxide Dismutase MimeticHypertension, 1998
- Cyclooxygenase Inhibition Restores Nitric Oxide Activity in Essential HypertensionHypertension, 1997
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976